These are characteristic manifestations of the severe form of COVID-19, which suggests that polymorphisms in the MBL2 gene that lead to MBL deficiency may significantly contribute to the systemic dysregulation of the organism. This evidence concerns the gene MBL2 and hyperinsulinemic hypoglycemia, familial, 4.